Business Context and Reporting Period
This Form 8-K filing by National Health Investors, Inc. (NHI) was submitted on December 15, 2025. The report discloses the execution of new Change in Control Severance Agreements with five named executive officers, replacing prior agreements dated February 26, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly a disclosure of executive compensation arrangements.
Material Changes
The primary material change is the update to severance terms for the following executives: D. Eric Mendelsohn, Kristin S. Gaines, Kevin C. Pascoe, John L. Spaid, and David L. Travis. Key changes include:
- Severance Multipliers: Lump sum cash payments are set at 3.0x for Mr. Mendelsohn, 2.0x for Messrs. Pascoe and Spaid, and 1.5x for Ms. Gaines and Mr. Travis. The base is the average of annual base salary and bonus for the most recent two consecutive calendar years.
- Triggering Events: Benefits apply if employment is terminated without "Cause" or for "Good Reason" within two years following a "Change in Control," or without "Cause" within 30 days prior to a "Change in Control."
- Additional Benefits: Includes a pro-rated target annual bonus, 18 months of COBRA coverage, and accelerated vesting of time-based equity awards.
- Restrictions: Messrs. Mendelsohn, Pascoe, and Spaid are subject to 12-month non-competition and non-solicitation restrictions post-termination if severance is paid. All executives are subject to confidentiality restrictions.
- Excise Tax Provision: Payments may be reduced to avoid Section 4999 excise tax if it results in greater net after-tax proceeds for the executive.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary contingency noted is the potential for significant cash outflows and accelerated equity vesting in the event of a Change in Control followed by qualifying terminations.
Investor Verification Checklist
- Verify the specific definitions of "Cause," "Good Reason," and "Change in Control" in the attached Exhibits 10.1 through 10.5.
- Review the current annual base salaries and bonus targets for the named executives to estimate potential severance liabilities.
- Assess the impact of the 12-month non-competition clauses on the company's ability to hire or retain key personnel in the event of a leadership transition.
- Confirm the status of any pending Change in Control transactions that might trigger these agreements.